SEC Form 4 · accession 0001179110-17-013629
SELECT MEDICAL HOLDINGS CORP · SEM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael E Tarvin
Officer — Executive Vice President
Period of report
Oct 30, 2017
Accepted (ET)
Nov 1, 2017 · 5:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001320414
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Oct 30, 2017 | S | 18,500 | $18.97 | D | 340,044 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Michael E. Tarvin on November 18, 2016.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.85 to $19.50, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.